CYP1A2 and prostate cancer: Among four case-control studies in Japan, one study each for colorectal, stomach, and prostate cancer investigated whether NAT2 acetylation genotype and CYP1A1 and CYP1A2 genotype modify the association between dietary HAA intake and risk of cancer [24, 25, 27].